Key information

🔎 Fund Overview

Sema4 Holdings Corp., formerly CM Life Sciences Inc., is a patient-centered health intelligence company that is focused on advancing healthcare through data-driven insights. The Company applies artificial intelligence and machine learning to clinical and genomic data to build models of human health and define individualized health trajectories. The Company’s health intelligence platform, Centrellis enables users to generate a complete understanding of disease and wellness and to provide science-driven solutions to pressing medical needs. Its Expanded Carrier Screen (ECS) is a carrier screen for inherited conditions. Its Noninvasive Prenatal Testing Solutions is a test that screens for autosomal and sex chromosome aneuploidies. Its Natalis Newborn Screening Solutions is a test of its screening portfolio allowing for detection of heritable conditions from pre-conception, pregnancy and childhood. The Company also includes Signal Precision Oncology Solutions.